Back
Qiagen NV 10K Form
Sell
43
QGEN
Qiagen NV
Last Price:
45.60
Seasonality Move:
5.83%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive QGEN News And Ratings
See the #1 stock for the next 7 days that we like better than QGEN
QGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.97B |
|---|---|
| Cash Flow: | $127.71M |
| Price / Cash Flow: | 25.2 |
| Annual Sales: | $15.32 |
| Price / Book: | 2.98 |
Profitability
| EPS (TTM): | 0.31710 |
|---|---|
| Net Income (TTM): | $72.7M |
| Gross Margin: | $1.23B |
| Return on Equity: | 2.01% |
| Return on Assets: | 1.22% |
Qiagen NV Earnings Forecast
Key Qiagen NV Financial Ratios
- The Gross Profit Margin over the past 29 years for QGEN is 62.77%.
- The Selling, General & Administrative Expenses for QGEN have been equal to 29.47% of Gross Profit Margin.
- The Research & Development expenses have been 10.10% of Revenue.
- The Interest Expense is 15.65% of Operating Income.
- The Net Earning history of QGEN is 17.37% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 18 years.
Qiagen NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | QGEN |
| CUSIP: | N72482 |
| Website: | qiagen.com |
Debt
| Debt-to-Equity Ratio: | 0.41 |
|---|---|
| Current Ratio: | 1.77 |
| Quick Ratio: | 1.2 |
Price-to-Earnings
| Trailing P/E Ratio: | 29.88 |
|---|---|
| Forward P/E Ratio: | 19.95 |